But which Biotechs do we own? There are so many of them!
Well, over the years, we've developed a number of tricks to help us identify which ones we may want to buy. One of those tricks is following insider activity, especially in an industry group like Biotechnology, where we know for a fact that we do NOT have any edge over the scientists who actually understand this stuff.
Also, not all insider activity is useful. Actually, most of it is garbage. That's why we created The Hot Corner—to show people the filings that actually matter.
In our years of following these filings, one insider has stood out among the rest: The Baker Bros.
The Baker Bros. are a hedge fund known for their razor-sharp focus and high-conviction bets on life sciences.
Most notably, these guys turned a $16 million stake in Seagen $SGEN into a $10 billion windfall when Pfizer bought them out in 2023.
It was one of the biggest single-trade returns in hedge fund history.